Taking these observations into account, almorexant and suvorexant, which displayed antagonist properties towards the Ca2+ signaling pathway, were full agonists able to activate the SHP2-dependant apoptosis signaling pathway in cancer cells [47]. The gene discussed is PTPN11; the disease is cancer.